Tech Company Financing Transactions

Atrin Pharmaceuticals Funding Round

Atrin Pharmaceuticals, based in Doylestown, secured $100 thousand in funding from Ben Franklin Technology Partners.

Transaction Overview

Announced On
3/31/2015
Transaction Type
Venture Equity
Amount
$100,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3805 Old Easton Rd.
Doylestown, PA 18902
USA
Email Address
Overview
Atrin Pharmaceuticals is a dynamic biopharmaceutical firm focused on the discovery and development of proprietary medications.
Profile
Atrin Pharmaceuticals LinkedIn Company Profile
Social Media
Atrin Pharmaceuticals Company Twitter Account
Company News
Atrin Pharmaceuticals News
Facebook
Atrin Pharmaceuticals on Facebook
YouTube
Atrin Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Oren Gilad
  Oren Gilad LinkedIn Profile  Oren Gilad Twitter Account  Oren Gilad News  Oren Gilad on Facebook
Chief Medical Officer
Rifat Pamucku
  Rifat Pamucku LinkedIn Profile  Rifat Pamucku Twitter Account  Rifat Pamucku News  Rifat Pamucku on Facebook
Chief Technical Officer
Dansu Li
  Dansu Li LinkedIn Profile  Dansu Li Twitter Account  Dansu Li News  Dansu Li on Facebook
VP - Bus. Development
Michael King
  Michael King LinkedIn Profile  Michael King Twitter Account  Michael King News  Michael King on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2015: Cytrellis Biosystems venture capital transaction
Next: 3/31/2015: Navitor Pharmaceuticals venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary